Table 2.
baseline characteristics.
| Study ID | N | Age, mean (SD), year | Sex, n(%) |
Structural heart disease n(%) | Multiple accessory pathways n(%) | Location of single accessory pathways n(%) |
Hypertension n(%) | Diabetes n(%) | Smoking n(%) | Renal failure n(%) | Heart failure n(%) | Congenital heart disease n(%) | Ischaemic heart disease n(%) | Valvular heart disease n(%) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | F | Left free wall | Right free wall |
Posteroseptal | Anteroseptal | |||||||||||||
| Brado 2021 | 789 | 42.8 ± 16.3 | 474(60.1) | 315(39.9) | – | – | 70(8.87) | – | – | – | – | 26(3.3) | – | – | – | – | 42(5.4) | 8(1) |
| Fujino 2020 | 475 | 38.2 ± 16.2 | 291(61) | 184(39) | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| GULLETTA 2013 | 41 | 13 ± 2.3047 | 25(61) | 16(39) | – | – | 18(43.9) | 4(9.75) | 12(29.26) | 4(9.75) | – | – | – | – | – | – | – | – |
| HOCINI 2015 | 7 | 45 ± 14.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Lin 2019 | 3051 | 36.267 ± 19.950 |
1988 (65.2) | 1063(34.8) | – | – | – | – | – | – | 275 (9.0) | 113 (3.7) | – | 12 (0.4) | 21 (0.7) | 34 (1.11) | 87 (2.9) | – |
| P. DiLorenzo 2012 | 12 | 14.625 ± 3.913 | – | – | – | – | – | – | – | 12(100) | – | – | – | – | – | 1(8.3) | – | – |
| Pietrzak 2020 | 86 | 27.5 ± 10.752907 |
55(63.9) | 31(36.1) | – | – | 53(66.25) | – | – | – | – | – | – | – | – | – | – | – |
| T. Brown 2021 | 33 | 34.9 ± 12.1 | 17 (51.5) | 16(49.5) | 6 (18.2) | – | – | – | 15(45.45) | 13(39.39) | 6 (18.2) | 2 (6.1) | – | – | – | – | 1 (3.0) | – |
| Uhm 2018 | 348 | 37.6 ± 17.3 | 203(58.33) | 145(41.66) | – | 13(3.735) | 176(50.5) | 78(22.41) | – | – | – | – | – | – | – | – | – | – |
| Ceresnak 2015 | 651 | 13 ± 4.0 | 378 (58) | 273(42) | – | 45 (7) | 256 (39) | 395 (61) | – | – | – | – | – | – | – | 59 (9) | – | 2(0.3) |
| Mudrić 2019 | 44 | 32 ± 15 | 29(65.90) | 15(34.09) | 1 (2) | – | 19 (43) | 5 (13) | – | – | 6 (14) | – | – | – | – | – | – | – |